NR5A1 and neoplasm: In conclusion, we have reported genetic engineering of a body‐temperature‐responsive and MMP‐cleavable protein‐polymer conjugate of IFNα‐MMPS‐ELP(V) with not only dramatically improved pharmacokinetics but also remarkably enhanced tumor accumulation and penetration, and antitumor efficacy.